These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11804366)

  • 1. Antiretroviral protease inhibitor therapy leads to hyperglycaemia, hyperlipidaemia and lipodystrophy.
    Sangraula H; Sharma KK; Dwivedi S
    Natl Med J India; 2001; 14(6):347-8. PubMed ID: 11804366
    [No Abstract]   [Full Text] [Related]  

  • 2. HIV-associated lipodystrophy, metabolic complications, and antiretroviral toxicities.
    Moyle G; Carr A
    HIV Clin Trials; 2002; 3(1):89-98. PubMed ID: 11894812
    [No Abstract]   [Full Text] [Related]  

  • 3. Photo quiz. Sunken cheeks.
    Kuwahara RT; Skinner RB
    Am Fam Physician; 2002 Apr; 65(7):1405-6. PubMed ID: 12004789
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effects of high grade antiretroviral therapy on body fat distribution and metabolism].
    Schwenk A
    Zentralbl Gynakol; 1999; 121(11):552-3. PubMed ID: 10612226
    [No Abstract]   [Full Text] [Related]  

  • 5. Breaking down lipodystrophy.
    Nutr Healthy Living; 2000; 5(1):4. PubMed ID: 11682763
    [No Abstract]   [Full Text] [Related]  

  • 6. Lipodystrophia with protease inhibitors in HIV patients.
    Massip P; Marchou B; Bonnet E; Cuzin L; Montastruc JL
    Therapie; 1997; 52(6):615. PubMed ID: 9734120
    [No Abstract]   [Full Text] [Related]  

  • 7. Changes in body shape and metabolic abnormalities.
    Res Initiat Treat Action; 1999 Jan; 5(1):18. PubMed ID: 11366225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lipodystrophy--an adverse effect of protease inhibitors used against HIV infection? Concern about negative delayed effects of this break-through].
    Morfeldt L; Jonsson B; Regnström J
    Lakartidningen; 1998 Oct; 95(42):4616-7. PubMed ID: 9814016
    [No Abstract]   [Full Text] [Related]  

  • 9. Metabolic effects of protease inhibitor therapy.
    Bernasconi E
    AIDS Read; 1999 Jul; 9(4):254-6, 259-60, 266-9. PubMed ID: 12737115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding and treating protease paunch.
    Vazquez E
    Posit Aware; 1999; 10(4):59-63. PubMed ID: 11366810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New PI may have limited lipid effects.
    AIDS Patient Care STDS; 2001 Sep; 15(9):496. PubMed ID: 11603363
    [No Abstract]   [Full Text] [Related]  

  • 12. Adverse drug reactions to protease inhibitors.
    Manchanda T; Schiedel D; Fischer D; Dekaban GA; Rieder MJ
    Can J Clin Pharmacol; 2002; 9(3):137-46. PubMed ID: 12422251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular complications of HIV.
    Alligood K; Terriff CM
    Prog Cardiovasc Nurs; 2000; 15(3):104-9. PubMed ID: 10951952
    [No Abstract]   [Full Text] [Related]  

  • 14. [Lipodystrophy and lipid metabolism alterations in HIV-infected patients receiving highly active antiretroviral therapy (HAART)].
    Calza L; Manfredi R; Chiodo F
    Recenti Prog Med; 2004 May; 95(5):265-75. PubMed ID: 15202680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protease inhibitor-associated hyperglycaemia.
    Dubé MP; Johnson DL; Currier JS; Leedom JM
    Lancet; 1997 Sep; 350(9079):713-4. PubMed ID: 9291911
    [No Abstract]   [Full Text] [Related]  

  • 16. Overcoming obstacles to the success of protease inhibitors in highly active antiretroviral therapy regimens.
    Moyle G
    AIDS Patient Care STDS; 2002 Dec; 16(12):585-97. PubMed ID: 12542932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dyslipidaemia associated with antiretroviral therapy in HIV-infected patients.
    Calza L; Manfredi R; Chiodo F
    J Antimicrob Chemother; 2004 Jan; 53(1):10-4. PubMed ID: 14645323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substitution for protease inhibitors in HIV therapy.
    Mikhail E
    N Engl J Med; 2003 Dec; 349(25):2460-1; author reply 2460-1. PubMed ID: 14689602
    [No Abstract]   [Full Text] [Related]  

  • 19. Antiretroviral treatment for HIV infection/AIDS and the risk of developing hyperglycemia and hyperlipidemia.
    de Araújo PS; de Alencar Ximenes RA; Lopes CF; Duarte JY; da Silva MM; Carneiro EM
    Rev Inst Med Trop Sao Paulo; 2007; 49(2):73-8. PubMed ID: 17505662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of apolipoproteins C3 and E with metabolic changes in HIV-infected adults treated with a protease-inhibitor-containing antiretroviral therapy.
    Bard JM; Lassalle R; Capeau J; Bach-Ngohou K; Nazih-Sanderson F; Rémy G; Reynes J; Ecobichon JL; Savès M; Raffi F;
    Antivir Ther; 2006; 11(3):361-70. PubMed ID: 16759053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.